Business description: PCAS

- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85

Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.87% | +6.78% | +53.76% | +158.55% | 1,070B | ||
| -0.33% | +5.10% | +62.45% | +55.06% | 611B | ||
| -0.46% | +6.69% | +31.91% | +85.62% | 445B | ||
| -3.05% | +4.18% | +31.11% | +23.88% | 329B | ||
| -1.74% | -0.40% | +33.19% | +33.55% | 290B | ||
| -1.25% | +0.53% | +27.68% | +41.18% | 287B | ||
| +2.99% | +4.00% | -26.09% | -40.14% | 213B | ||
| -0.32% | +2.77% | +24.32% | +60.52% | 195B | ||
| +0.15% | +1.04% | +13.18% | +64.84% | 157B | ||
| Average | -0.40% | +5.04% | +27.95% | +53.67% | 399.58B | |
| Weighted average by Cap. | -0.60% | +6.67% | +38.63% | +79.01% |

















